PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. eterpos@med.uoa.gr.\', \'Faculty of Freiburg, Hematology and Oncology Department, Interdisciplinary Cancer Center (ITZ) and Comprehensive Cancer Center Freiburg (CCCF), University of Freiburg, Freiburg, Germany.\', \'Leeds Cancer Centre, Leeds Teaching Hospitals National Health Service Trust and University of Leeds, Leeds, UK.\', \'Division of Hematology, University of Turin, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.\', \'Cancer Research Unit, University Hospital of Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.\', \'Institute of Cancer Molecular and Cellular Biology (USAL-CSIC), Centre for Cancer Research (IBMCC), Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.\', \'Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.\', \'Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.\', \'Genomics of Myeloma Laboratory, L\'Institut Universitaire du Cancer Oncopole, Toulouse, France.\', \'Department of Hemato-Oncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.\', \'Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.\', \'Wilhelminen Cancer Research Institute, c/o Department of Medical Oncology, Hematology and Palliative Care, Wilhelminenspital Wien, Austria.\', \'Department of Hematology, University Hospital Hotel-Dieu, Nantes, France.\', \'Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.\', \'Clínica Universidad de Navarra-Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Centro de Investigación Biomédica en Red de Cáncer, Pamplona, Spain.\', \'Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41375-020-0876-z
?:hasPublicationType
?:journal
  • Leukemia
is ?:pmid of
?:pmid
?:pmid
  • 32444866
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.131
?:rankingScore_hIndex
  • 168
is ?:relation_isRelatedTo_publication of
?:title
  • Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN).
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32444866>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32444866>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all